Therapeutic injection into a sinus tract — instilling medication directly into the pathologic channel to treat ongoing infection or inflammation.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $128.59
- Total RVUs
- 3.85
- Global, days
- 10
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Identify the sinus tract by anatomic location — generic 'wound' descriptions fail audit
- Name the injected agent, concentration, and volume administered
- State the clinical indication and why therapeutic injection was selected over alternative management
- Confirm the tract is established (not an acute puncture wound) to support the code selection
- If billed same-day with another procedure, document that the sinus tract injection was a distinct service at a separate site or for a separate clinical purpose
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 20500 covers the therapeutic injection of a sinus tract: introducing a medicinal agent (e.g., antibiotic solution, sclerosing agent, or corticosteroid) into an established abnormal channel in soft tissue. The code carries a 10-day global period, meaning routine follow-up within that window is bundled. The companion code 20501 covers the diagnostic sinogram (contrast injection for imaging purposes) — do not report both for the same tract at the same encounter without clear documentation of distinct clinical intent.
The NCCI Policy Manual explicitly prohibits using 20500 to report administration of local anesthetic for a separate surgical procedure — that use is a misuse of the code. If local anesthesia is required to perform the injection itself, it's included; it does not create a separate billable event. When the procedure is performed as a distinct service unrelated to any other same-day procedure, append modifier 59 or an X-modifier to defend separate reportability if a payer edit fires.
The extreme payment differential between HOPD and ASC settings is worth noting when authorizations are obtained — payers may direct site-of-service based on this gap. Documentation must clearly identify the sinus tract by location, the agent injected, the volume, and the clinical rationale. Operative or procedure notes that describe only 'wound care' or 'wound injection' without naming the tract will fail audit.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 1.25 |
| Practice expense RVU | 2.45 |
| Malpractice RVU | 0.15 |
| Total RVU | 3.85 |
| Medicare national rate | $128.59 |
| Global period | 10 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $128.59 |
HOPD (APC 5163) Hospital outpatient department | $1,585.19 |
ASC (PI P3) Ambulatory surgical center (freestanding) | $82.24 |
Common denial reasons
The recurring reasons claims for CPT 20500 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Operative note describes 'wound care' or 'local anesthetic injection' without identifying a discrete sinus tract — payer downcodes or denies
- 20500 and 20501 billed at the same encounter for the same tract without distinct documentation of therapeutic versus diagnostic intent
- 20500 denied as bundled when the injected agent is local anesthetic preparatory to a separately billed surgical procedure — NCCI prohibits this use
- Missing clinical indication linking the sinus tract diagnosis code (ICD-10 L98.x or site-specific equivalent) to the procedure on the claim
- 10-day global period violation: follow-up visit billed within 10 days without modifier 24 for an unrelated E/M service
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Can I bill 20500 and 20501 at the same encounter?
02Can 20500 be used to report injecting local anesthetic before another procedure?
03What modifier do I use if the same sinus tract needs re-injection during the 10-day global?
04Is modifier 50 appropriate for bilateral sinus tract injections?
05Does the 10-day global period affect same-day E/M billing?
06Which diagnosis codes support medical necessity for 20500?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 03novitas-solutions.comhttps://www.novitas-solutions.com/webcenter/portal/MedicareJH/pagebyid?contentId=00085606
- 04emedny.orghttps://www.emedny.org/providermanuals/physician/pdfs/physician%20procedure%20codes%20sect5.pdf
- 05aaos.orghttps://www.aaos.org/globalassets/quality-and-practice-resources/coding-and-reimbursement/resident-guide/resident-guide_modifiers.pdf
Mira AI Scribe
Mira's AI scribe captures the sinus tract's anatomic location, the name and volume of the injected agent, and the clinical rationale from dictation — ensuring the note says 'therapeutic injection of established sinus tract' rather than the audit-flagging 'wound injection.' That specificity prevents the most common denial: payer downcoding when the procedure note reads as routine wound care.
See how Mira captures CPT 20500 documentation